T1	Parsing_Error 0 2	1.
T2	Parsing_Error 191 193	2.
T3	Parsing_Error 320 322	3.
T4	Parsing_Error 413 415	4.
T5	Parsing_Error 764 766	5.
T6	Parsing_Error 844 846	1.
T7	Parsing_Error 870 872	2.
T8	Parsing_Error 960 962	3.
T9	Parsing_Error 1216 1218	4.
T10	Parsing_Error 1292 1294	5.
T11	Parsing_Error 1375 1377	6.
T12	Parsing_Error 1521 1523	6.
T13	Parsing_Error 1578 1580	7.
T14	Parsing_Error 2107 2109	8.
T15	Parsing_Error 3503 3506	20.
T16	Parsing_Error 3388 3391	19.
T17	Parsing_Error 3181 3184	18.
T18	Parsing_Error 3037 3040	17.
T19	Parsing_Error 2946 2949	16.
T20	Parsing_Error 2867 2870	15.
T21	Parsing_Error 2777 2780	14.
T22	Parsing_Error 2669 2672	13.
T23	Parsing_Error 2570 2573	12.
T24	Parsing_Error 2469 2472	11.
T25	Parsing_Error 2394 2397	10.
T26	Parsing_Error 2230 2232	9.
T27	Drug 21 32	doxorubicin
T28	Drug 34 37	PLD
T29	Drug 51 64	anthracycline
T30	Drug 66 75	motolimod
T31	Drug 86 98	TLR agonists
T32	Drug 100 108	MEDI4736
T33	Drug 112 133	checkpoint inhibitors
T34	Drug 143 153	anti-CTLA4
T35	Drug 158 166;178 188	anti-PD1 antibodies
T36	Drug 167 188	anti-PD-L1 antibodies
T37	Scope 143 188	anti-CTLA4 and anti-PD1/anti-PD-L1 antibodies
*	OR T34 T35 T36
T38	Grammar_Error 154 157	and
R1	Subsumes Arg1:T33 Arg2:T37	
*	OR T33 T32 T31 T30 T29 T28 T27
T39	Temporal 3 8	Prior
T40	Scope 21 188	doxorubicin, PLD or any other anthracycline, motolimod and other TLR agonists, MEDI4736 or checkpoint inhibitors, such as anti-CTLA4 and anti-PD1/anti-PD-L1 antibodies
R2	Has_temporal Arg1:T40 Arg2:T39	
T41	Condition 208 235	platinum-refractory disease
T42	Undefined_semantics 208 235	platinum-refractory disease
T43	Condition 248 267	disease progression
T44	Temporal 268 317	while receiving first line platinum-based therapy
T45	Reference_point 284 317	first line platinum-based therapy
R3	Has_index Arg1:T44 Arg2:T45	
R4	Has_temporal Arg1:T43 Arg2:T44	
R5	Subsumes Arg1:T41 Arg2:T43	
T46	Condition 357 386	immune-related adverse events
T47	Temporal 387 410	following prior therapy
T48	Reference_point 397 410	prior therapy
R6	Has_index Arg1:T47 Arg2:T48	
R7	Has_temporal Arg1:T46 Arg2:T47	
T49	Qualifier 323 345	Clinically significant
T50	Qualifier 346 356	persistent
R8	Has_qualifier Arg1:T46 Arg2:T50	
R9	Has_qualifier Arg1:T46 Arg2:T49	
T51	Subjective_judgement 323 345	Clinically significant
T52	Undefined_semantics 323 345	Clinically significant
T53	Condition 479 490	CNS disease
T54	Condition 502 521	primary brain tumor
T55	Condition 523 531	seizures
T56	Qualifier 536 546	controlled
T57	Negation 532 535	not
T58	Drug 552 576	standard medical therapy
R10	AND Arg1:T56 Arg2:T58	
R11	Has_negation Arg1:T56 Arg2:T57	
R12	Has_qualifier Arg1:T55 Arg2:T56	
*	OR T54 T55 T59 T68
T59	Condition 582 598	brain metastases
T60	Temporal 604 650	within six months prior to Day 1 of this study
T61	Reference_point 631 650	Day 1 of this study
R13	Has_index Arg1:T60 Arg2:T61	
T62	Condition 663 687	cerebrovascular accident
T63	Condition 689 692	CVA
T64	Condition 694 700	stroke
*	OR T63 T64
T65	Scope 689 700	CVA, stroke
R14	Subsumes Arg1:T62 Arg2:T65	
T66	Condition 703 734	transient ischemic attack (TIA)
T67	Condition 738 761	subarachnoid hemorrhage
*	OR T66 T67 T62
T68	Scope 663 761	cerebrovascular accident (CVA, stroke), transient ischemic attack (TIA) or subarachnoid hemorrhage
R15	Has_temporal Arg1:T68 Arg2:T60	
T69	Condition 804 826	cardiovascular disease
T70	Qualifier 781 803	clinically significant
T71	Subjective_judgement 781 803	clinically significant
T72	Undefined_semantics 781 803	clinically significant
R16	Has_qualifier Arg1:T69 Arg2:T70	
T73	Parsing_Error 828 842	This includes:
T74	Condition 847 868	Resisted hypertension
T75	Condition 873 894	Myocardial infarction
T76	Condition 898 913	unstable angina
T77	Temporal 914 957	within 6 months prior to Day 1 of the study
T78	Reference_point 939 957	Day 1 of the study
R17	Has_index Arg1:T77 Arg2:T78	
T79	Condition 982 1004	ventricular arrhythmia
*	OR T76 T75
T80	Scope 873 913	Myocardial infarction or unstable angina
R18	Has_temporal Arg1:T80 Arg2:T77	
T81	Condition 1012 1035	ventricular tachycardia
T82	Condition 1039 1063	ventricular fibrillation
*	OR T82 T81
T83	Scope 1012 1063	ventricular tachycardia or ventricular fibrillation
R19	Subsumes Arg1:T79 Arg2:T83	
T84	Qualifier 974 981	serious
T85	Observation 963 970	History
T86	Condition 1068 1087	cardiac arrhythmias
T87	Drug 1098 1125	anti-arrhythmic medications
T88	Qualifier 1088 1125	requiring anti-arrhythmic medications
R20	AND Arg1:T88 Arg2:T87	
R21	Has_qualifier Arg1:T86 Arg2:T88	
T89	Condition 1138 1157	atrial fibrillation
T90	Negation 1127 1133	except
T91	Qualifier 1166 1213	well controlled with anti-arrhythmic medication
T92	Drug 1187 1213	anti-arrhythmic medication
R22	AND Arg1:T91 Arg2:T92	
R23	Has_qualifier Arg1:T89 Arg2:T91	
R24	Has_negation Arg1:T89 Arg2:T90	
R25	AND Arg1:T86 Arg2:T89	
R26	Has_qualifier Arg1:T79 Arg2:T84	
*	OR T86 T79
R27	Has_temporal Arg1:T79 Arg2:T85	
R28	Has_temporal Arg1:T86 Arg2:T85	
T93	Measurement 1228 1245	ejection fraction
T94	Temporal 1219 1227	Baseline
T95	Value 1246 1251	â‰¤ 50%
R29	Has_value Arg1:T93 Arg2:T95	
R30	Has_temporal Arg1:T93 Arg2:T94	
T96	Procedure 1267 1281	echocardiogram
T97	Procedure 1285 1289	MUGA
*	OR T97 T96
T98	Scope 1267 1289	echocardiogram or MUGA
R31	Has_scope Arg1:T93 Arg2:T98	
T99	Measurement 1295 1328	New York Heart Association (NYHA)
T100	Value 1329 1347	Class II or higher
R32	Has_value Arg1:T99 Arg2:T100	
T101	Condition 1348 1372	congestive heart failure
R33	AND Arg1:T101 Arg2:T99	
T102	Condition 1396 1415	peripheral ischemia
T103	Qualifier 1378 1395	Grade 2 or higher
T104	Value 1384 1395	2 or higher
R34	Has_value Arg1:T103 Arg2:T104	
R35	Has_qualifier Arg1:T102 Arg2:T103	
T105	Temporal 1428 1433	brief
T106	Value 1435 1443	< 24 hrs
R36	Subsumes Arg1:T105 Arg2:T106	
T107	Condition 1457 1465	ischemia
T108	Procedure 1478 1488	surgically
T109	Negation 1474 1477	non
R37	Has_negation Arg1:T108 Arg2:T109	
R38	AND Arg1:T107 Arg2:T108	
T110	Condition 1501 1518	permanent deficit
T111	Negation 1493 1500	without
R39	Has_negation Arg1:T110 Arg2:T111	
R40	AND Arg1:T107 Arg2:T110	
R41	Has_temporal Arg1:T107 Arg2:T105	
T112	Negation 1417 1423	except
T113	Scope 1428 1518	brief (< 24 hrs) episodes of ischemia managed non-surgically and without permanent deficit
R42	Has_negation Arg1:T113 Arg2:T112	
R43	Has_scope Arg1:T102 Arg2:T113	
T114	Condition 1535 1546	pneumonitis
T115	Condition 1550 1575	interstitial lung disease
*	OR T115 T114
T116	Observation 1524 1531	History
R44	Has_temporal Arg1:T114 Arg2:T116	
R45	Has_temporal Arg1:T115 Arg2:T116	
T117	Condition 1619 1637	autoimmune disease
T118	Condition 1649 1675	inflammatory bowel disease
T119	Condition 1677 1691	celiac disease
T120	Condition 1693 1716	Wegner's granulomatosis
T121	Condition 1725 1748	Hashimoto's thyroiditis
T122	Condition 1750 1770	rheumatoid arthritis
T123	Condition 1772 1777	lupus
T124	Condition 1779 1790	scleroderma
T125	Condition 1779 1790;1799 1807	scleroderma variants
T126	Condition 1809 1827	multiple sclerosis
T127	Condition 1829 1846	myasthenia gravis
*	OR T127 T126 T125 T124 T123 T122 T121 T120 T119 T118
T128	Scope 1649 1846	inflammatory bowel disease, celiac disease, Wegner's granulomatosis, active Hashimoto's thyroiditis, rheumatoid arthritis, lupus, scleroderma and its variants, multiple sclerosis, myasthenia gravis
R46	Subsumes Arg1:T117 Arg2:T128	
T129	Condition 1849 1857	Vitiligo
T130	Condition 1859 1883	type I diabetes mellitus
T131	Condition 1885 1908	residual hypothyroidism
T132	Condition 1916 1936	autoimmune condition
T133	Qualifier 1909 1936	due to autoimmune condition
R47	AND Arg1:T133 Arg2:T132	
R48	Has_qualifier Arg1:T131 Arg2:T133	
*	OR T130 T131 T129
T134	Drug 1952 1971	hormone replacement
T135	Qualifier 1942 1971	requiring hormone replacement
R49	AND Arg1:T135 Arg2:T134	
R50	Has_qualifier Arg1:T132 Arg2:T135	
T136	Qualifier 1987 2015	requiring systemic treatment
T137	Procedure 1997 2015	systemic treatment
T138	Negation 1983 1986	not
R51	Has_negation Arg1:T136 Arg2:T138	
R52	AND Arg1:T136 Arg2:T137	
T139	Condition 1973 1982	psoriasis
R53	Has_qualifier Arg1:T139 Arg2:T136	
T140	Qualifier 2031 2052	not expected to recur
T141	Subjective_judgement 2031 2052	not expected to recur
T142	Condition 2020 2030	conditions
T143	Undefined_semantics 2020 2030	conditions
R54	Has_qualifier Arg1:T142 Arg2:T140	
*	OR T139 T142 T132
T144	Temporal 2127 2169	within 2 years prior to Day 1 of the study
T145	Reference_point 2151 2169	Day 1 of the study
R55	Has_index Arg1:T144 Arg2:T145	
T146	Condition 2116 2126	malignancy
R56	Has_temporal Arg1:T146 Arg2:T144	
T147	Procedure 2201 2222	surgical intervention
T148	Negation 2171 2181	except for
R57	Has_negation Arg1:T147 Arg2:T148	
T149	Condition 2182 2187	those
R58	AND Arg1:T149 Arg2:T147	
T150	Undefined_semantics 2182 2187	those
R59	AND Arg1:T146 Arg2:T149	
T151	Condition 2247 2264;2274 2305	clinical symptoms of gastrointestinal obstruction
T152	Condition 2268 2305	signs of gastrointestinal obstruction
T153	Device 2325 2350	drainage gastrostomy tube
T154	Procedure 2358 2378	parenteral hydration
T155	Procedure 2358 2368;2382 2391	parenteral nutrition
*	OR T153 T155 T154 T151 T152
T156	Condition 2404 2420	immunodeficiency
T157	Condition 2424 2427	HIV
T158	Condition 2429 2440	Hepatitis B
T159	Condition 2444 2455	Hepatitis C
*	OR T159 T158 T157 T156
T160	Condition 2491 2509	allergic reactions
T161	Qualifier 2484 2490	severe
R60	Has_qualifier Arg1:T160 Arg2:T161	
T162	Observation 2473 2480	History
T164	Drug 2510 2567	to any unknown allergens or components of the study drugs
T165	Context_Error 2510 2567	to any unknown allergens or components of the study drugs
R61	AND Arg1:T160 Arg2:T164	
R62	Has_temporal Arg1:T160 Arg2:T162	
T163	Condition 2588 2597	illnesses
T166	Qualifier 2580 2587	serious
T167	Subjective_judgement 2580 2587	serious
T168	Undefined_semantics 2580 2587	serious
T169	Condition 2613 2645	infections requiring antibiotics
T170	Undefined_semantics 2613 2645	infections requiring antibiotics
T171	Qualifier 2605 2612	serious
R63	Has_qualifier Arg1:T169 Arg2:T171	
T172	Condition 2647 2665	bleeding disorders
*	OR T169 T172
T173	Scope 2605 2665	serious infections requiring antibiotics, bleeding disorders
R64	Has_qualifier Arg1:T163 Arg2:T166	
R65	Has_scope Arg1:T163 Arg2:T173	
T174	Procedure 2679 2688	treatment
T175	Context_Error 2673 2775	Prior treatment in any other interventional clinical trial within 4 weeks prior to Day 1 of the study.
T177	Condition 2781 2798	Mental impairment
T178	Observation 2808 2829	compromise compliance
R66	Has_context Arg1:T177 Arg2:T178	
T179	Context_Error 2781 2865	Mental impairment that may compromise compliance with the requirements of the study.
T182	Observation 2964 2977	breastfeeding
T183	Condition 2981 2989	pregnant
T184	Person 2950 2955	Women
T185	Measurement 3015 3035	serum pregnancy test
T186	Value 3006 3014	positive
R67	Has_value Arg1:T185 Arg2:T186	
*	OR T183 T182
T187	Scope 2964 2989	breastfeeding or pregnant
R68	AND Arg1:T187 Arg2:T185	
T190	Person 3106 3112	Female
T191	Observation 3142 3155	breastfeeding
T193	Temporal 3156 3179	throughout this period.
T194	Reference_point 3167 3178	this period
R69	Has_index Arg1:T193 Arg2:T194	
T198	Non-query-able 3185 3386	Any condition that, in the clinical judgment of the treating physician, is likely to prevent the subject from complying with any aspect of the protocol or that may put the subject at unacceptable risk.
T199	Procedure 3410 3422	donate blood
T200	Negation 3406 3409	not
R70	Has_negation Arg1:T199 Arg2:T200	
T201	Temporal 3423 3437	while on study
T202	Reference_point 3429 3437	on study
R71	Has_index Arg1:T201 Arg2:T202	
T203	Temporal 3442 3500	for at least 90 days following the last MEDI4736 treatment
T204	Reference_point 3473 3500	the last MEDI4736 treatment
R72	Has_index Arg1:T203 Arg2:T204	
T205	Scope 3423 3500	while on study and for at least 90 days following the last MEDI4736 treatment
R73	Has_scope Arg1:T199 Arg2:T205	
T206	Procedure 3518 3545	allogeneic organ transplant
T207	Observation 3507 3514	History
R74	Has_temporal Arg1:T206 Arg2:T207	
T176	Temporal 2673 2678	Prior
R75	Has_temporal Arg1:T174 Arg2:T176	
A1	Optional T190
T188	Negation 3129 3141	refrain from
R76	Has_temporal Arg1:T191 Arg2:T193	
R77	Has_negation Arg1:T191 Arg2:T188	
R78	Has_context Arg1:T190 Arg2:T191	
T180	Negation 2871 2878	Lack of
T181	Procedure 2896 2909;2923 2943	immunological follow-up assessment
T189	Procedure 2914 2943	clinical follow-up assessment
*	OR T181 T189
T192	Scope 2896 2943	immunological and clinical follow-up assessment
R79	Has_negation Arg1:T192 Arg2:T180	
T195	Mood 2879 2895	availability for
R80	Has_mood Arg1:T192 Arg2:T195	
T196	Condition 3050 3059	unwilling
T208	Qualifier 3067 3077	acceptable
T209	Procedure 3089 3102	contraception
R81	Has_qualifier Arg1:T209 Arg2:T208	
R82	AND Arg1:T196 Arg2:T209	
